Interesterified Oil

Chemical Identifier:

Randomized Acylglycerols

☡Risk Level Summary☡

While interesterified oils successfully avoid the specific cardiovascular markers associated with trans fats (the LDL/HDL ratio), they introduce a different set of metabolic concerns. Research suggests they may be "metabolically confusing" to the body. Because the fatty acids are placed in positions on the glycerol molecule that rarely occur in nature (specifically the sn-2 position), the body’s lipase enzymes process them differently, potentially leading to issues with blood sugar and fat storage.

Biological Impact & Mechanism

The primary biological concern with interesterified oil is its impact on glucose metabolism and lipid transport.

Insulin Response: Human clinical trials have shown that interesterified fats can raise blood glucose levels and depressed insulin responses more significantly than even trans fats.

Lipid Rearrangement: By placing saturated fats in the sn-2 position (the middle "prong" of the triglyceride), these fats are absorbed more efficiently into the bloodstream, which may bypass some of the body's natural regulatory checks for fat absorption.

Liver Stress: There is emerging evidence that these synthetic fat structures may contribute to increased fat accumulation in the liver.

Historical & Common Use

Interesterification has existed as a laboratory concept since the 1920s, but it was not economically viable for mass production. Its use surged in the mid-2000s and reached total market saturation after the 2018 FDA ban on partially hydrogenated oils. It is now the "standard" fat used in commercial cookies, crackers, and tub margarines.

Consumer Sentiments

Sentiments are currently characterized by unawareness followed by suspicion. Most consumers are unaware that "trans-fat-free" often means "interesterified." Once informed, there is a general feeling that the food industry has simply replaced one "franken-fat" with another that hasn't been studied for long-term multi-generational effects.

Consumer Reports of Health Effects and Symptoms

Because interesterified oils are a newer addition to the food supply, specific "symptoms" are often grouped with general ultra-processed food consumption. However, reports include:

Post-Prandial Lethargy: Extreme "slump" after consuming baked goods containing these fats.

Blood Sugar Fluctuation: Difficulty maintaining stable glucose levels in individuals with pre-diabetes.

Digestive Heaviness: A coating sensation in the mouth and slow digestion.

FDA & Other Regulatory Authorities

FDA Status: Interesterified oils are currently classified as GRAS (Generally Recognized As Safe).

Ruling: As of the 2018 Trans Fat Ban, the FDA allowed interesterification as a primary replacement technology.

Findings: The FDA has not issued a warning against interesterified fats, as they do not show the same direct link to heart disease as trans fats. However, researchers continue to submit data regarding their impact on blood glucose, which may prompt a future review.

EFSA (European Food Safety Authority): As of April 2021, the EU implemented a limit on industrial trans fats (2g per 100g of fat), which effectively mandated the use of interesterification or palm oil blends across Europe. EFSA maintains that current intake levels of IE fats are not a safety concern but notes the need for more research on sn-2 palmitic acid positioning.

Asia (WHO Western Pacific): Many Asian nations, including Singapore and Thailand (effective 2019), followed the WHO "REPLACE" action package to eliminate trans fats. Consequently, interesterified oils have become the dominant industrial fat in Asian bakery exports to the West. No specific restrictions on interesterification exist in these regions as of 2026.

The PurePath™ Standard Swap

✅

Virgin Coconut Oil, Grass-fed Butter, Ghee, Leaf Lard, Beef Tallow, Sustainably Sourced Red Palm Oil.

Subscribe to Interesterified Oil